Form D · Other Energy

Synata Bio, Inc.

Warrenville, IL · CIK 0001658888

Offering snapshot reported Feb 1, 2021 · SEC filing

Reported sold
$606K
Offering amount: $1M
Investors reported
4
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Oct 17, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 1, 2021Initial$606,188No comparison4SEC filing
Jan 30, 2018Amendment$30,000,000$10,000,000vs Apr 10, 20171SEC filing
Apr 11, 2017Amendment$47,000,000$5,500,000vs Dec 9, 20161SEC filing
Apr 10, 2017Amendment$20,000,000$10,000,000vs Nov 24, 20151SEC filing
Dec 9, 2016Initial$41,500,000No comparison1SEC filing
Nov 24, 2015Initial$10,000,000No comparison1SEC filing

Offering details

Securities
Option to acquire, Security to be acquired
Exemptions
04
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-388041

Source: Form D, filed Feb 1, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Matthew S Ahearn Director
Michael J Ahearn Director, Executive
Mary Bjorklund Executive
Alan E Henderson Director
Steven D Kloos Director
Jay K Kouba Director
Mj J Maloof Executive
Jeremy Patt Executive
Steve Sloma Executive
Macy Stoneback Executive

Issuer details

Industry: Other Energy (See others in industry)

Address:
4575 Weaver Parkway Suite 100
Warrenville, IL, 60555